<html>
        <head>
            <link rel="stylesheet" type="text/css" href="layout.css" />
        </head>
        <style> 
            .right { 
                margin-left: 160px;
            } 
        </style>
        
        <div class="sidenav">
            <a href="#">About</a>
            <a href="index_gpt.html">Index</a>
        </div>
    <div class="header"><h3>Transfusion Strategies for Acute Upper Gastrointestinal Bleeding</h3></div><p><span class="main">"Restrictive versus Liberal Transfusion Strategy in Patients with Acute Upper Gastrointestinal Bleeding".The New England Journal of Medicine. 2013. 368:11-21. </span></p><p><span class="contents">
                                        Links to original sources:
                                        <a href=https://www.wikijournalclub.org//wiki/Transfusion_Strategies_for_Acute_Upper_Gastrointestinal_Bleeding>Wiki Journal Post</a>
                                        <a href=http://www.nejm.org/doi/full/10.1056/NEJMoa1211801>Full Journal Article</a>
                                        </span></p><h2><span class="labels">Clinical Question</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">In patients with acute upper gastrointestinal bleeding, is a restrictive transfusion strategy (transfusion at Hb <7 g/dL) more effective and safer than a liberal transfusion strategy (transfusion at Hb <9 g/dL)?
 </span></p><h2><span class="labels">Bottom Line</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Among patients with acute upper gastrointestinal bleeding, a restrictive transfusion strategy (Hb threshold for transfusion, <7 g/dL) improved survival rates and other clinical outcomes compared with a liberal transfusion strategy (Hb threshold for transfusion, <9 g/dL).
 </span></p><h2><span class="labels">Major Points</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">A restrictive transfusion strategy (transfusing when Hb <7 g/dL) led to higher survival rates at 6 weeks (95% vs. 91%) and decreased rates of repeat bleeding and adverse events compared with a liberal transfusion strategy (transfusing when Hb <9 g/dL) in patients with upper gastrointestinal bleeding.
 </span></p><h2><span class="labels">Guidelines</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Following the results of this trial, international guidelines suggest lowering the Hb threshold for transfusion in patients with gastrointestinal bleeding from 10 g/dL to 7 g/dL.
 </span></p><h2><span class="labels">Design</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">- Multicenter, randomized, controlled trial
- N=921 patients with acute upper gastrointestinal bleeding
- Restrictive strategy (n=461), liberal strategy (n=460)
- Setting: Single center in Barcelona, Spain
- Enrollment: 2003-2009
- Follow up: 45 days
- Analysis: Intention-to-treat
- Primary outcome: All-cause mortality at 45 days
 </span></p><h2><span class="labels">Population</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Inclusion Criteria:
- Patients ≥18 years old with hematemesis, melena, or both
- Hospital staff confirmation of bleeding
 </span></p><p><span class="main">Exclusion Criteria:
- Refusal of blood transfusion
- Massive exsanguinating bleeding, recent acute coronary syndrome, symptomatic peripheral vasculopathy, stroke, recent trauma or surgery, lower GI bleeding, recent transfusion, clinical Rockall score of 0 with Hb >12 g/dL
 </span></p><p><span class="main">Baseline Characteristics
- Similar between groups
- 31% had cirrhosis
- Bleeding source: peptic ulcer (49%), esophageal varices (21%)
 </span></p><h2><span class="labels">Interventions</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">- Restrictive strategy: Transfuse if Hb <7 g/dL
- Liberal strategy: Transfuse if Hb <9 g/dL
- Followed until discharge or death
- Protocol deviations allowed for clinically significant anemia, massive rebleeding, or need for surgical intervention
 </span></p><h2><span class="labels">Outcomes</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Primary Outcomes
- 45-day all-cause mortality: Restrictive group 5% vs. Liberal group 9% (P=0.02)
 </span></p><h2><span class="labels">Outcomes</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">- Further bleeding: Restrictive group 10% vs. Liberal group 16% (P=0.01)
- In-hospital complications: Restrictive group 40% vs. Liberal group 48% (P=0.02)
 </span></p><h2><span class="labels">Criticisms</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">- Not generalizable to all patients with gastrointestinal bleeding, such as those with low-risk or massive exsanguinating hemorrhage
- Potential bias due to non-blinded design
 </span></p><h2><span class="labels">Funding</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">- Fundació Investigació Sant Pau
 </span></p><h2><span class="labels">Further Reading</span></h2> <hr width="88.5%", align = "right", size="2"><p><span class="main">Updates to the article and related letters can be found at NEJM.org. </span></p>    	
        <div class="footer">Footer</div>
        </body>
        </html>